Results 31 to 40 of about 9,320,431 (225)

Acknowledgement to Reviewers of Information in 2016

open access: yesInformation, 2017
The editors of Information would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Information Editorial Office
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2015

open access: yesInformation, 2016
The editors of Information would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Information Editorial Office
doaj   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2018

open access: yesInformation, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing [...]
Information Editorial Office
doaj   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

A short chronicle of warfare in South Africa

open access: yesScientia Militaria, 2012
Khoisan Wars Khoisan is the collective name for the South African people known as Hottentots and Bushmen. It is compounded from the first part of Khoi Khoin (men of men) as the Hottentots called themselves, and San, the names given by the Hottentots ...
Military Information Bureau
doaj   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2013

open access: yesInformation, 2014
The editors of Information would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Information Editorial Office
doaj   +1 more source

Language, Culture, and Cancer: Qualitative Insights Into Communication Disparities Among Spanish‐Speaking Caregivers of Children With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Latino children are projected to make up nearly one‐third of United States (US) children by 2060, and many of their caregivers speak Spanish. Prior survey research has documented communication difficulties for Spanish‐speaking caregivers of children with cancer, but contemporary qualitative data are limited.
Jenny Ruiz   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy